SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-278976
Filing Date
2014-07-24
Accepted
2014-07-24 16:33:01
Documents
2
Period of Report
2014-07-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d762792d8k.htm 8-K 20242
2 AMENDED AND RESTATED BYLAWS OF THE COMPANY d762792dex31.htm EX-3.1 101535
  Complete submission text file 0001193125-14-278976.txt   123120
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 14991672
SIC: 8731 Services-Commercial Physical & Biological Research